1. Home
  2. ZEO vs COEP Comparison

ZEO vs COEP Comparison

Compare ZEO & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEO
  • COEP
  • Stock Information
  • Founded
  • ZEO 2005
  • COEP 2017
  • Country
  • ZEO United States
  • COEP United States
  • Employees
  • ZEO N/A
  • COEP N/A
  • Industry
  • ZEO
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ZEO
  • COEP Health Care
  • Exchange
  • ZEO NYSE
  • COEP Nasdaq
  • Market Cap
  • ZEO 31.6M
  • COEP 32.4M
  • IPO Year
  • ZEO N/A
  • COEP N/A
  • Fundamental
  • Price
  • ZEO $2.16
  • COEP $12.45
  • Analyst Decision
  • ZEO
  • COEP
  • Analyst Count
  • ZEO 0
  • COEP 0
  • Target Price
  • ZEO N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • ZEO 1.8M
  • COEP 111.8K
  • Earning Date
  • ZEO 03-18-2025
  • COEP 03-25-2025
  • Dividend Yield
  • ZEO N/A
  • COEP N/A
  • EPS Growth
  • ZEO N/A
  • COEP N/A
  • EPS
  • ZEO N/A
  • COEP N/A
  • Revenue
  • ZEO $77,582,314.00
  • COEP N/A
  • Revenue This Year
  • ZEO N/A
  • COEP N/A
  • Revenue Next Year
  • ZEO N/A
  • COEP N/A
  • P/E Ratio
  • ZEO N/A
  • COEP N/A
  • Revenue Growth
  • ZEO N/A
  • COEP N/A
  • 52 Week Low
  • ZEO $1.05
  • COEP $2.31
  • 52 Week High
  • ZEO $11.60
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • ZEO 43.33
  • COEP 63.21
  • Support Level
  • ZEO $2.04
  • COEP $8.65
  • Resistance Level
  • ZEO $2.86
  • COEP $12.95
  • Average True Range (ATR)
  • ZEO 0.24
  • COEP 1.64
  • MACD
  • ZEO -0.07
  • COEP -0.16
  • Stochastic Oscillator
  • ZEO 14.63
  • COEP 75.25

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: